Stereotaxis Partners with NVIDIA to Innovate Medical Robotics

Author: Dylan Bailey Updated: 03-19-2025 08:33 AM

NVIDIA Recognizes Stereotaxis at GTC Conference

Stereotaxis (NYSE: STXS), a leader in surgical robotics for minimally invasive endovascular intervention, caught the attention of NVIDIA at the GTC Conference, an event dedicated to artificial intelligence (AI) advancements. With over 25,000 innovators gathered in San Jose, NVIDIA spotlighted Stereotaxis’ cutting-edge technology, emphasizing the integration of AI in robotic surgeries.

The Impact of NVIDIA's Support

During a significant keynote at the GTC event, NVIDIA’s Vice President of Healthcare and Life Sciences showcased Stereotaxis’ robotic systems, heralding a new era for medical technology. The partnership has also led to Stereotaxis being invited into the NVIDIA Connect program, a unique initiative that offers comprehensive software resources, frameworks, and development kits to member companies.

Advancing Robotic Surgery with AI

Stereotaxis is not just a pioneer in trauma management; their robotic technologies are now at the forefront of advancing minimally-invasive surgical procedures. With over 150,000 patients treated globally using its robots across more than 100 leading hospitals, Stereotaxis is making significant strides in improving patient outcomes.

The company is now transitioning towards digital solutions that further enhance the functionality of their robotic systems.” This new phase includes artificial intelligence, robotic automation, and advanced data integration features that allow for better decision-making support during surgeries.

Leadership Insights and Future Directions

David Fischel, the Chairman and CEO of Stereotaxis, expressed gratitude for NVIDIA’s collaborative efforts in pioneering endovascular robotics. He stated, “The fusion of robotics’ mechanistic advantages—precision and stability—with AI innovations will revolutionize patient treatment possibilities.” This collaboration signals an exciting future for robotics in medicine, as Stereotaxis gears up for further advancements in surgical technology.

About Stereotaxis

Stereotaxis specializes in robotic surgical systems tailored for the interventional laboratory. By focusing on robotics, the company aims to enhance patient care with precise interventions while simultaneously expanding accessibility to minimally invasive therapies. Their technology has made a significant impact by treating patients worldwide.

Contact Information for Inquiries

If you are interested in learning more about Stereotaxis and its innovative technologies, please reach out to the following:

David L. Fischel
Chairman and Chief Executive Officer
Kimberly Peery
Chief Financial Officer
Phone: 314-678-6100
Email: Investors@Stereotaxis.com

Frequently Asked Questions

What is Stereotaxis known for?

Stereotaxis is recognized as a global leader in surgical robotics, specifically focusing on minimally invasive endovascular interventions.

What did NVIDIA highlight at the GTC Conference?

NVIDIA showcased Stereotaxis’ innovative surgical robots and their efforts to integrate AI into robotic surgery during their keynote address.

How many patients have been treated with Stereotaxis technology?

More than 150,000 patients have benefited from treatments using Stereotaxis robotic systems in various hospitals worldwide.

What support does the NVIDIA Connect program provide?

NVIDIA Connect offers member companies like Stereotaxis access to advanced software development resources and tools to enhance their technology.

Who leads Stereotaxis?

The company is led by David L. Fischel as the Chairman and CEO, with Kimberly Peery serving as the Chief Financial Officer.

About The Author

My name is Dylan Bailey, and I am 28 years old. I am an author and an expert on the stock market who specializes in publicly traded companies. Early fascination with the stock market inspired me to seek a finance degree and then delve deeply into the world of stocks. I have developed over the years my abilities to spot investment prospects, assess business performance, and analyze market trends.

My books and articles try to help regular investors understand the nuances of the stock market. Anyone can, in my opinion, make wise investment choices and succeed financially if they have the correct information and resources. In my writing, I combine in-depth research with practical insights and advice that can be put into action. This is done with the intention of assisting readers in navigating the constantly shifting landscape of publicly traded companies.

In addition to writing, I also host webinars and workshops, where I give presentations and share my knowledge with a wider audience. I also write for top financial journals and show up as a guest analyst on financial news shows. I like to travel, spend time with my family, and keep active by playing different sports when I'm not buried in market research.

My goal is to enable people to choose wisely and consciously in their investments, so taking charge of their financial futures. By my work, I hope to create a community of informed and self-assured investors prepared to take advantage of the chances presented by the stock market.

Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.